Vidotto T - Search Results

1

Emerging role of PTEN loss in evasion of the immune response to tumours.

Vidotto T, Melo CM, Castelli E, Koti M, Dos Reis RB, Squire JA. Vidotto T, et al. Br J Cancer. 2020 Jun;122(12):1732-1743. doi: 10.1038/s41416-020-0834-6. Epub 2020 Apr 24. Br J Cancer. 2020. PMID: 32327707 Free PMC article. Review.

2

PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells.

Vidotto T, Saggioro FP, Jamaspishvili T, Chesca DL, Picanço de Albuquerque CG, Reis RB, Graham CH, Berman DM, Siemens DR, Squire JA, Koti M. Vidotto T, et al. Prostate. 2019 Jun;79(9):969-979. doi: 10.1002/pros.23808. Epub 2019 Apr 18. Prostate. 2019. PMID: 30999388

3

DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes.

Vidotto T, Nersesian S, Graham C, Siemens DR, Koti M. Vidotto T, et al. J Immunother Cancer. 2019 Jun 7;7(1):148. doi: 10.1186/s40425-019-0619-8. J Immunother Cancer. 2019. PMID: 31174611 Free PMC article.

4

Risk Stratification of Prostate Cancer Through Quantitative Assessment of PTEN Loss (qPTEN).

Jamaspishvili T, Patel PG, Niu Y, Vidotto T, Caven I, Livergant R, Fu W, Kawashima A, How N, Okello JB, Guedes LB, Ouellet V, Picanço C, Koti M, Reis RB, Saad F, Mes-Masson AM, Lotan TL, Squire JA, Peng YP, Siemens DR, Berman DM. Jamaspishvili T, et al. Among authors: vidotto t. J Natl Cancer Inst. 2020 Nov 1;112(11):1098-1104. doi: 10.1093/jnci/djaa032. J Natl Cancer Inst. 2020. PMID: 32129857 Free PMC article.

5

The Role of Somatic Mutations on the Immune Response of the Tumor Microenvironment in Prostate Cancer.

Melo CM, Vidotto T, Chaves LP, Lautert-Dutra W, Reis RBD, Squire JA. Melo CM, et al. Among authors: vidotto t. Int J Mol Sci. 2021 Sep 2;22(17):9550. doi: 10.3390/ijms22179550. Int J Mol Sci. 2021. PMID: 34502458 Free PMC article. Review.

6

Distinct subtypes of genomic PTEN deletion size influence the landscape of aneuploidy and outcome in prostate cancer.

Vidotto T, Tiezzi DG, Squire JA. Vidotto T, et al. Mol Cytogenet. 2018 Jan 3;11:1. doi: 10.1186/s13039-017-0348-y. eCollection 2018. Mol Cytogenet. 2018. PMID: 29308088 Free PMC article.

7

High throughput assessment of biomarkers in tissue microarrays using artificial intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer cohorts.

Harmon SA, Patel PG, Sanford TH, Caven I, Iseman R, Vidotto T, Picanço C, Squire JA, Masoudi S, Mehralivand S, Choyke PL, Berman DM, Turkbey B, Jamaspishvili T. Harmon SA, et al. Among authors: vidotto t. Mod Pathol. 2021 Feb;34(2):478-489. doi: 10.1038/s41379-020-00674-w. Epub 2020 Sep 3. Mod Pathol. 2021. PMID: 32884130 Free PMC article.

8

In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in situ hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading.

Picanço-Albuquerque CG, Morais CL, Carvalho FL, Peskoe SB, Hicks JL, Ludkovski O, Vidotto T, Fedor H, Humphreys E, Han M, Platz EA, De Marzo AM, Berman DM, Lotan TL, Squire JA. Picanço-Albuquerque CG, et al. Among authors: vidotto t. Virchows Arch. 2016 May;468(5):607-17. doi: 10.1007/s00428-016-1904-2. Epub 2016 Feb 9. Virchows Arch. 2016. PMID: 26861919

9

Sexual Dimorphism in Outcomes of Non-muscle-invasive Bladder Cancer: A Role of CD163+ Macrophages, B cells, and PD-L1 Immune Checkpoint.

Chenard S, Jackson C, Vidotto T, Chen L, Hardy C, Jamaspishvilli T, Berman D, Siemens DR, Koti M. Chenard S, et al. Among authors: vidotto t. Eur Urol Open Sci. 2021 Jun 3;29:50-58. doi: 10.1016/j.euros.2021.05.002. eCollection 2021 Jul. Eur Urol Open Sci. 2021. PMID: 34337534 Free PMC article.

10

Increased STAT1 Expression in High Grade Serous Ovarian Cancer Is Associated With a Better Outcome.

Josahkian JA, Saggioro FP, Vidotto T, Ventura HT, Candido Dos Reis FJ, de Sousa CB, Tiezzi DG, de Andrade JM, Koti M, Squire JA. Josahkian JA, et al. Among authors: vidotto t. Int J Gynecol Cancer. 2018 Mar;28(3):459-465. doi: 10.1097/IGC.0000000000001193. Int J Gynecol Cancer. 2018. PMID: 29303938

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters